PCR fluorescence
-
Ua hui pū ʻia nā pathogens hanu
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka SARS-CoV-2, ka maʻi influenza A, ka maʻi influenza B, ka maʻi influenza A H1N1 a me nā waikawa nucleic virus syncytial hanu i loko o nā ʻāpana swab oropharyngeal kanaka a me nā ʻāpana swab nasopharyngeal.
-
Pahu ʻike waikawa nukleika Legionella Pneumophila
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o ka legionella pneumophila nucleic acid i loko o nā laʻana sputum o nā maʻi me ka maʻi legionella pneumophila i manaʻo ʻia, a hāʻawi i ke kōkua i ka ʻike ʻana o nā maʻi me ka maʻi legionella pneumophila.
-
29 ʻAno o nā pathogens hanu i hui pū ʻia me ka waikawa nucleic
Hoʻohana ʻia kēia kime no ka ʻike qualitative o ka coronavirus novel (SARS-CoV-2), ka maʻi Influenza A (IFV A), ka maʻi maʻi Influenza B (IFV B), ka maʻi syncytial Respiratory (RSV), Adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (Rhv), ʻano virus Parainfluenza kanaka I/II/III (HBvirus) (EV), Coronavirus (CoV), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), a me Streptococcus pneumoniae (SP) a me ka maʻi maʻi Influenza A subtype H1N1(2009)/H1/H3/H5/H7/H9/H10, ka maʻi maʻi influenza B Yamagata/Victoria, Human coronavirusE/HCoV-L-29N HCoV-HKU1/ MERS-CoV/ SARS-CoV mau ʻakika nucleic i loko o ka swab oropharyngeal kanaka a nā hāpana swab nasopharyngeal.
-
Ka nui o ka waikawa nucleic o ka maʻi influenza B
Hoʻohana ʻia kēia pahu hana no ka ʻike nui ʻana o ka waikawa nucleic virus influenza B i loko o nā hāpana swab oropharyngeal kanaka in vitro.
-
ʻAno Adenovirus 41 Nucleic Acid
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka adenovirus nucleic acid i loko o nā hāpana ʻōpala in vitro.
-
ʻO Klebsiella Pneumoniae, Acinetobacter Baumannii a me Pseudomonas Aeruginosa a me nā Genes Resistance Drug (KPC, NDM, OXA48 a me IMP) Multiplex
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka Klebsiella pneumoniae (KPN), Acinetobacter baumannii (Aba), Pseudomonas aeruginosa (PA) a me ʻehā mau genes kūʻē carbapenem (e komo pū ana me KPC, NDM, OXA48 a me IMP) i loko o nā laʻana sputum kanaka, e hāʻawi i ke kumu o ke alakaʻi ʻana i ka hōʻailona lapaʻau, ka mālama ʻana a me ka lāʻau lapaʻau no nā poʻe maʻi me ka maʻi bacteria i manaʻo ʻia.
-
ʻO ka waikawa nucleic Chlamydia Pneumoniae
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka Chlamydia pneumoniae (CPN) nucleic acid i loko o ka sputum kanaka a me nā laʻana swab oropharyngeal.
-
ʻO ka waikawa nucleic o ka maʻi syncytial hanu
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o ka respiratory syncytial virus nucleic acid i loko o ka swab nasopharyngeal kanaka, nā laʻana swab oropharyngeal, a hāʻawi nā hopena hoʻāʻo i ke kōkua a me ke kumu i ka ʻike a me ka mālama ʻana i ka maʻi respiratory syncytial virus.
-
ʻO ka maʻi influenza A H3N2 Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka maʻi influenza A H3N2 nucleic acid i nā laʻana swab nasopharyngeal kanaka.
-
ʻO ka maʻi Influenza maloʻo-hau/Maʻi Influenza B waikawa Nucleic
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative in vitro o ka maʻi influenza A (IFV A) a me ka maʻi influenza B (IFV B) RNA i loko o nā hāpana swab nasopharyngeal kanaka.
-
ʻEono mau pathogens hanu i hoʻomaloʻo ʻia me ka hau Nucleic Acid
Hoʻohana ʻia kēia huahana no ka ʻike ʻana i ka qualitative in vitro o ka respiratory syncytial virus (RSV), adenovirus (Adv), human metapneumovirus (hMPV), rhinovirus (Rhv), parainfluenza virus type I/II/III (PIVI/II/III) a me Mycoplasma pneumoniae (MP) nucleic acids i loko o nā laʻana swab nasopharyngeal kanaka.
-
14 ʻAno o ka Human Papillomavirus Kiʻekiʻe-pilikia (16/18/52 Typing) Nucleic Acid
Hoʻohana ʻia ke kime no ka ʻike ʻana i ka qualitative in vitro o 14 mau ʻano o nā human papillomaviruses (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) nā ʻāpana nucleic acid kikoʻī i loko o nā laʻana mimi kanaka, nā laʻana swab cervical wahine, a me nā laʻana swab vaginal wahine, a me ke ʻano HPV 16/18/52, e kōkua i ka ʻike ʻana a me ka mālama ʻana i ka maʻi HPV.
